Shantanu Sheorey [SHAQUAK] vs Saregama India [SAREGAMA] Detailed Stock Comparison
Shantanu Sheorey
BSE
Loading...
Saregama India
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Shantanu Sheorey wins in 5 metrics, Saregama India wins in 10 metrics, with 0 ties. Saregama India appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Shantanu Sheorey | Saregama India | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.80 | 45.60 | Shantanu Sheorey |
| Price-to-Book Ratio | 0.28 | 5.90 | Shantanu Sheorey |
| Debt-to-Equity Ratio | 23.62 | 0.17 | Saregama India |
| PEG Ratio | -0.22 | 13.38 | Shantanu Sheorey |
| EV/EBITDA | -86.12 | 30.94 | Shantanu Sheorey |
| Profit Margin (TTM) | 0.00% | 17.39% | Saregama India |
| Operating Margin (TTM) | 0.00% | 18.28% | Saregama India |
| EBITDA Margin (TTM) | N/A | 18.28% | N/A |
| Return on Equity | -0.74% | 12.87% | Saregama India |
| Return on Assets (TTM) | -0.59% | 9.75% | Saregama India |
| Free Cash Flow (TTM) | $-1.22M | $1.70B | Saregama India |
| Dividend Yield | N/A | 0.86% | N/A |
| 1-Year Return | -2.34% | 3.26% | Saregama India |
| Price-to-Sales Ratio (TTM) | N/A | 7.93 | N/A |
| Enterprise Value | $99.81M | $87.21B | Saregama India |
| EV/Revenue Ratio | N/A | 7.44 | N/A |
| Gross Profit Margin (TTM) | N/A | 92.63% | N/A |
| Revenue per Share (TTM) | $0 | $61 | Saregama India |
| Earnings per Share (Diluted) | $-0.03 | $10.59 | Saregama India |
| Beta (Stock Volatility) | -0.38 | 0.81 | Shantanu Sheorey |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Shantanu Sheorey vs Saregama India Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Shantanu Sheorey | -0.60% | -1.76% | 1.83% | 7.74% | -4.57% | -18.54% |
| Saregama India | 2.63% | 4.67% | 0.34% | -9.40% | -7.74% | 3.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Shantanu Sheorey | -2.34% | -20.85% | 138.57% | -98.76% | -34.51% | -34.51% |
| Saregama India | 3.26% | 23.88% | 951.89% | 1,002.42% | 484.15% | 168.06% |
Performance & Financial Health Analysis: Shantanu Sheorey vs Saregama India
| Metric | SHAQUAK | SAREGAMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹58.25M | ₹93.02B |
| Market Cap Category | Small cap | Mid cap |
| 10 Day Avg. Volume | 8,717 | 603,085 |
| 90 Day Avg. Volume | 10,410 | 553,491 |
| Last Close | ₹1.67 | ₹495.65 |
| 52 Week Range | ₹1.25 - ₹2.20 | ₹417.40 - ₹688.90 |
| % from 52W High | -24.09% | -28.05% |
| All-Time High | ₹315.00 (Oct 31, 2016) | ₹688.90 (Sep 30, 2024) |
| % from All-Time High | -99.47% | -28.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.01% |
| Quarterly Earnings Growth | N/A | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.17% |
| Operating Margin (TTM) | 0.00% | 0.18% |
| Return on Equity (TTM) | -0.01% | 0.13% |
| Debt to Equity (MRQ) | 23.62 | 0.17 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹5.92 | ₹81.89 |
| Cash per Share (MRQ) | ₹0.00 | ₹33.94 |
| Operating Cash Flow (TTM) | ₹-1,247,000 | ₹3.36B |
| Levered Free Cash Flow (TTM) | ₹-1,175,000 | ₹2.04B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.86% |
| Last 12-Month Dividend | N/A | ₹4.50 |
Valuation & Enterprise Metrics Analysis: Shantanu Sheorey vs Saregama India
| Metric | SHAQUAK | SAREGAMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.80 | 45.60 |
| Forward P/E | N/A | 34.48 |
| PEG Ratio | -0.22 | 13.38 |
| Price to Sales (TTM) | N/A | 7.93 |
| Price to Book (MRQ) | 0.28 | 5.90 |
| Market Capitalization | ||
| Market Capitalization | ₹58.25M | ₹93.02B |
| Enterprise Value | ₹99.81M | ₹87.21B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | 7.44 |
| Enterprise to EBITDA | -86.12 | 30.94 |
| Risk & Other Metrics | ||
| Beta | -0.38 | 0.81 |
| Book Value per Share (MRQ) | ₹5.92 | ₹81.89 |
Financial Statements Comparison: Shantanu Sheorey vs Saregama India
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SHAQUAK | SAREGAMA |
|---|---|---|
| Revenue/Sales | ₹0 | ₹2.41B |
| Cost of Goods Sold | ₹0 | ₹939.80M |
| Gross Profit | ₹0 | ₹1.47B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-734,000 | ₹637.20M |
| EBITDA | ₹-734,000 | ₹979.70M |
| Pre-Tax Income | ₹-749,000 | ₹816.20M |
| Income Tax | ₹0 | ₹217.60M |
| Net Income (Profit) | ₹-749,000 | ₹598.60M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SHAQUAK | SAREGAMA |
|---|---|---|
| Cash & Equivalents | ₹53,000 | ₹693.90M |
| Total Current Assets | ₹193.51M | ₹12.03B |
| Total Current Liabilities | ₹19.64M | ₹4.18B |
| Long-Term Debt | ₹21.20M | ₹14.10M |
| Total Shareholders Equity | ₹158.05M | ₹15.87B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹2.24B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SHAQUAK | SAREGAMA |
|---|---|---|
| Operating Cash Flow | N/A | ₹578.91M |
| Capital Expenditures | N/A | ₹-195.45M |
| Free Cash Flow | N/A | ₹-627.15M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | ₹-44.78M |
Short Interest & Institutional Ownership Analysis
| Metric | SHAQUAK | SAREGAMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 8,717 | 603,085 |
| Average Daily Volume (90 Day) | 10,410 | 553,491 |
| Shares Outstanding | 34.88M | 192.35M |
| Float Shares | 25.70M | 78.38M |
| % Held by Insiders | 0.25% | 0.65% |
| % Held by Institutions | 0.00% | 0.10% |
Dividend Analysis & Yield Comparison: Shantanu Sheorey vs Saregama India
| Metric | SHAQUAK | SAREGAMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹4.50 |
| Last 12-Month Dividend Yield | N/A | 0.86% |
| 3-Year Avg Annual Dividend | N/A | ₹3.83 |
| 3-Year Avg Dividend Yield | N/A | 0.92% |
| 3-Year Total Dividends | N/A | ₹11.50 |
| Ex-Dividend Date | N/A | Feb 14, 2025 |